Could we see a more bullish buy signal? Insiders are buying a NON-BROKERED private placement of debentures yielding 8% just after having announced that the company will begin to sell two new products in major provinces of Canada. The stock was also recommended by IA Capital Markets analyst Chelsea Stellick that raised her share target for Valeo Pharma ($1.14) to $3.10 from $2.20
...more